MA16.01 Frequency and Genomic Context of Emerging Markers for Molecular Testing in Lung Adenocarcinoma in Cell-Free DNA NGS Analysis

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.09-10 Circulating Cell-Free DNA (cfDNA) Molecular Profile of Thai NSCLC Patients Using Difference Variant Frequency of NGS

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.03-02 Cell-Free DNA (cfDNA) Testing in Lung Adenocarcinoma (LUAC) Patients: Spanish Lung Liquid Versus Invasive Biopsy Program (SLLIP)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA24.02 Genomic Alterations in Lung Adenocarcinoma Precursor Lesions

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Noninvasive Prenatal Testing From Cell-Free DNA

CMAJ
Medicine
2014English

Implementation of Maternal Blood Cell-Free DNA Testing in Early Screening for Aneuploidies

Medizinische Genetik
Genetics
2019English

DNA Markers in Molecular Diagnostics for Hepatocellular Carcinoma

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2014English

P2.01-66 Comparison of EGFR Mutation Status in Tissue and Plasma Cell-Free DNA Detected by ARMS in Advanced Lung Adenocarcinoma Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Circulating Tumor DNA Analysis Depicts Subclonal Architecture and Genomic Evolution of Small Cell Lung Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Cell-Surface Markers for Colon Adenoma and Adenocarcinoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy